Authors

Ethics Committee of the American Society for Reproductive Medicine

Volume 100, Issue 3, Pages 645-650, September 2013

Abstract

Cross-border reproductive care (CBRC) is a growing worldwide phenomenon, raising questions about why assisted reproductive technology (ART) patients travel abroad, what harms and benefits may result, and what duties health care providers may have in advising and treating patients who travel for reproductive services. Cross-border care offers benefits and poses harms to ART stakeholders, including patients, offspring, providers, gamete donors, gestational carriers, and local populations in destination countries.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00396-8/fulltext